| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 297,779 | 316,018 | 245,354 | 327,071 | | Cost of Revenue | (77,523) | 28,503 | 49,020 | 54,869 | | | Gross Profit | 375,302 | 287,515 | 196,334 | 272,202 | | | Operating Expenses | | Research Development |
-
| (4,346) | 4,346 | 5,456 | | Selling General and Administrative | 318,207 | 210,278 | 131,092 | 122,759 | | Non Recurring |
-
| (10,695) | 699 | 592 | | Others | 8,263 | 8,773 | 8,187 | 14,754 | | | | Total Operating Expenses |
-
| 204,010 | 144,324 | 143,561 | | | | Operating Income or Loss | 46,163 | 83,505 | 52,010 | 128,641 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 15,947 | | Earnings Before Interest And Taxes | 48,832 | 83,505 | 52,010 | 144,588 | | Interest Expense | (924) | 2,612 | 981 | 1,589 | | Income Before Tax | 49,756 | 80,893 | 51,029 | 142,999 | | Income Tax Expense | 19,278 | 32,934 | 21,148 | 61,395 | | Minority Interest |
-
|
-
|
-
| (1,902) | | | | Net Income From Continuing Ops | 30,478 | 47,959 | 29,881 | 79,702 | | | Non-recurring Events | | Discontinued Operations | (1,253) | (12,461) | (20,514) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,225 | 35,498 | 9,367 | 79,702 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,225 | $35,498 | $9,367 | $79,702 |
|
0.02% Nasdaq 0.00%
Income Statement
